Parenteral nutrition‐associated liver disease/cholestasis · Parenterally fed preterm infants
All fish oil containing LE showed no clear difference in parenteral nutrition‐associated liver disease/cholestasis compared with S‐LE (low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes acute rejection episodes compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
All‐cause mortality · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with omega‐3 fish oil changes mortality compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
PNALD/cholestasis (conjugated bilirubin ≥ 2 mg/dL) – pure F‐LE vs S‐LE · parenterally fed term and late preterm infants with surgical conditions
It is very uncertain whether fish oil LE changes PNALD/cholestasis (conjugated bilirubin ≥ 2 mg/dL) Pure F‐LE vs S‐LE compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Resolution of PNALD/cholestasis (conjugated bilirubin less than2 mg/dL) Pure F‐LE vs S‐LE · parenterally fed term and late preterm infants
It is very uncertain whether fish oil LE changes resolution of PNALD/cholestasis (conjugated bilirubin less than2… compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Growth · parenterally fed term and late preterm infants
1 finding from 1 review
Any sepsis (clinical and/or culture positive) · parenterally fed term and late preterm infants
It is very uncertain whether fish oil LE changes any sepsis (clinical or culture positive (or both)) MOFS‐LE vs S‐LE… compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Hypertriglyceridaemia · parenterally fed term and late preterm infants
It is very uncertain whether fish oil LE changes hypertriglyceridaemia compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Conjugated bilirubin levels · parenterally fed term and late preterm infants
1 finding from 1 review
ALP U/L · parenterally fed term and late preterm infants
1 finding from 1 review
Rate of change of conjugated bilirubin · parenterally fed term and late preterm infants
1 finding from 1 review
Mortality before hospital discharge · parenterally fed term and late preterm infants
It is very uncertain whether fish oil LE changes death before discharge compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Parenteral nutrition‐associated liver disease/cholestasis · parenterally fed term and late preterm infants with surgical conditions
Fish oil LE showed no clear difference in PNALD/cholestasis (any definition) compared with non‐fish oil LE (low certainty).
1 finding from 1 review
Culture‐positive sepsis · parenterally fed term and late preterm infants with surgical conditions
It is very uncertain whether fish oil LE changes culture‐positive sepsis compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Hypertriglyceridaemia · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
Conjugated bilirubin levels · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
ALP U/L · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
Mortality before hospital discharge · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review